2005
DOI: 10.1016/j.cyto.2005.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Exogenous interleukin-6 increases cold allodynia in rats with a mononeuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 32 publications
0
23
0
Order By: Relevance
“…Generally there has been a trend of endogenous IL-6 having pro-nociceptive effects on exaggerated pain states as revealed by use of anti-IL-6 neutralizing antibodies (Arruda et al, 2000;Chacur et al, 2004;DeLeo et al, 1996;Milligan et al, 2003); present study) and exogenous IL-6 having anti-nociceptive effects as revealed by administration of IL-6 protein (Choi et al, 2003;Flatters et al, 2003). However, three studies using exogenous IL-6 did report pro-nociceptive effects (DeLeo et al, 1996;Oka et al, 1995;Vissers et al, 2005). Comparison of the dosages between these studies does not indicate that these differences in effects are seen because of low vs. high drug doses, as these studies used several different drug doses.…”
Section: Discussionmentioning
confidence: 39%
See 2 more Smart Citations
“…Generally there has been a trend of endogenous IL-6 having pro-nociceptive effects on exaggerated pain states as revealed by use of anti-IL-6 neutralizing antibodies (Arruda et al, 2000;Chacur et al, 2004;DeLeo et al, 1996;Milligan et al, 2003); present study) and exogenous IL-6 having anti-nociceptive effects as revealed by administration of IL-6 protein (Choi et al, 2003;Flatters et al, 2003). However, three studies using exogenous IL-6 did report pro-nociceptive effects (DeLeo et al, 1996;Oka et al, 1995;Vissers et al, 2005). Comparison of the dosages between these studies does not indicate that these differences in effects are seen because of low vs. high drug doses, as these studies used several different drug doses.…”
Section: Discussionmentioning
confidence: 39%
“…Also, IL-6 in combination with its soluble receptor can sensitize skin nociceptors to heat (Obreja et al, 2002;Opree and Kress, 2000). Thus, both endogenous IL-6 (Arruda et al, 2000;Chacur et al, 2004;Milligan et al, 2003), as in the present study, and exogenous IL-6 (DeLeo et al, 1996;Vissers et al, 2005) have been reported to have pronociceptive effects. Moreover, in IL-6 knockout mice, mechanical allodynia that is induced in wild-type mice following chronic constriction injury or spinal nerve injury is absent or delayed compared to wild-type mice, further indicating that endogenous IL-6 may mediate hypersensitivity responses associated with neuropathic pain (Murphy et al, 1999;Ramer et al, 1998).…”
Section: Discussionmentioning
confidence: 63%
See 1 more Smart Citation
“…All these studies support IL-6 being the downstream effector of the calpain-2-triggered pain pathway following motor nerve injury. Although IL-6 is critically involved in the cascade of events after nerve injury leading to the development and maintenance of pain behaviors (DeLeo et al, 1996;Dubovy et al, 2013;Vissers et al, 2005;Wei et al, 2013a), the peripheral mechanism by which IL-6 elicits nociception is still largely unknown. Our previous work has shown that TNF-a through triggering the abnormal Na + channels expression increases the excitability of primary afferents after L5-VRT (Chen et al, 2011), which contributes to neuropathic pain by sequentially leading to the central sensitization.…”
Section: Calpain-2 Triggers Il-6 Up-regulation In Drg Neuronsmentioning
confidence: 99%
“…It has been shown that exogenous administration of IL-6 is sufficient to stimulate nociceptors and cause pain [11,52,53]. It has been reported, however, that an increase in plasma IL-6 did not induce a hyperalgesic effect that would indicate IL-6 effects in the nervous structures, e.g., in DRG or the spinal cord [53,54].…”
Section: Discussionmentioning
confidence: 99%